Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Atrial natriuretic factor. Current data and future perspectives].

J B Michel1, J F Arnal

  • 1INSERM unité 36, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periodontitis and Cardiovascular Diseases. Consensus Report.

Global heart·2020
Same author

Inflammation increases MMP levels via PGE<sub>2</sub> in human vascular wall and plasma of obese women.

International journal of obesity (2005)·2018
Same author

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.

International journal of cardiology·2017
Same author

Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.

Cardiovascular diabetology·2016
Same author

Estrogens are needed for the improvement in endothelium-mediated dilation induced by a chronic increase in blood flow in rat mesenteric arteries.

Vascular pharmacology·2015
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Atrial natriuretic factor (ANF) plays a key role in heart failure. Inhibiting ANF metabolism enhances its therapeutic effects, offering new cardiovascular treatment strategies.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pharmacology

Context:

  • Atrial natriuretic factor (ANF) research has advanced significantly since its discovery.
  • Recent studies focus on ANF biosynthesis and secretion in heart failure.
  • Cyclic GMP (cGMP) levels correlate with ANF production and serve as a prognostic indicator.

Purpose:

  • To review the physiology, pharmacology, and biochemistry of ANF.
  • To discuss the physiopathological aspects of ANF in heart failure.
  • To explore therapeutic strategies targeting ANF metabolism.

Summary:

  • ANF receptors, including particulate guanylate cyclase and clearance receptors, have been cloned.
  • Neutral endopeptidase cleaves ANF, reducing its efficacy.

Related Experiment Videos

  • Blocking ANF metabolism via clearance receptor antagonists or neutral endopeptidase inhibitors potentiates ANF's biological effects, especially on renal function.

    • Impact:

    • ANF gene over-expression and peripheral cGMP are independent prognostic indicators in heart failure.
    • Inhibiting ANF metabolism presents a promising therapeutic approach for cardiovascular diseases.
    • This strategy enhances the effects of both exogenous and endogenous ANF, particularly in renal function modulation.